Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The effect of warfarin administration on platelet aggregation

M. Chylova, Z. Motovska, A. Fialova, I. Stetkarova, T. Peisker, P. Kalvach

. 2021 ; 122 (5) : 320-324.

Language English Country Slovakia

Document type Clinical Study, Research Support, Non-U.S. Gov't

BACKGROUND: The aim of this study was to assess the effect of anticoagulation treatment on platelet aggregation. METHODS: The study group consisted of 24 patients on long-term warfarin therapy without any antiaggregation therapy. Platelet aggregation was measured using VerifyNow with arachidonic acid (AA) as an inducer in 23 patients and with light transmission aggregometry (LTA) in 19 patients using four different agonists. All patients had their international normalized ratio (INR) checked regularly. RESULTS: The mean INR value was 2.07 (SD 0.6). The average aggregation measured by VerifyNow was found to be 637.5 (SD 36.6) aspirin reaction units. The values of average aggregability in LTA were 73.3 % (SD 4.5 %), 73.2 % (SD 6 %) and 72.1 % (SD 4.8 %) in case of aggregation induced by AA, ADP, and collagen, respectively. Epinephrine-induced aggregability was 65.3 % (SD 14.7 %). Regression analysis between INR and values of collagen- or epinephrine-induced aggregability (r = 0.654 and 0.575) was found statistically signifi cant (p = 0.004 and 0.016); every increase in INR by 0,1 brings about an increase in collagen- and epinephrine-induced aggregation values by 1.5 and 4, respectively. CONCLUSION: Administration of warfarin does not produce a signifi cant reduction in platelet aggregation. On the contrary, prolonged INR evokes a mild increase in aggregation induced by collagen or epinephrine (Tab. 2, Fig. 3, Ref. 32).

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21027359
003      
CZ-PrNML
005      
20250218232656.0
007      
cr|cn|
008      
211026s2021 xo d fs 000 0|eng||
009      
AR
024    0_
$a 10.4149/BLL_2021_054 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xo
100    1_
$a Chýlová, Miroslava $7 xx0256464 $u Department of Neurology, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
245    14
$a The effect of warfarin administration on platelet aggregation / $c M. Chylova, Z. Motovska, A. Fialova, I. Stetkarova, T. Peisker, P. Kalvach
504    __
$a Literatura
520    9_
$a BACKGROUND: The aim of this study was to assess the effect of anticoagulation treatment on platelet aggregation. METHODS: The study group consisted of 24 patients on long-term warfarin therapy without any antiaggregation therapy. Platelet aggregation was measured using VerifyNow with arachidonic acid (AA) as an inducer in 23 patients and with light transmission aggregometry (LTA) in 19 patients using four different agonists. All patients had their international normalized ratio (INR) checked regularly. RESULTS: The mean INR value was 2.07 (SD 0.6). The average aggregation measured by VerifyNow was found to be 637.5 (SD 36.6) aspirin reaction units. The values of average aggregability in LTA were 73.3 % (SD 4.5 %), 73.2 % (SD 6 %) and 72.1 % (SD 4.8 %) in case of aggregation induced by AA, ADP, and collagen, respectively. Epinephrine-induced aggregability was 65.3 % (SD 14.7 %). Regression analysis between INR and values of collagen- or epinephrine-induced aggregability (r = 0.654 and 0.575) was found statistically signifi cant (p = 0.004 and 0.016); every increase in INR by 0,1 brings about an increase in collagen- and epinephrine-induced aggregation values by 1.5 and 4, respectively. CONCLUSION: Administration of warfarin does not produce a signifi cant reduction in platelet aggregation. On the contrary, prolonged INR evokes a mild increase in aggregation induced by collagen or epinephrine (Tab. 2, Fig. 3, Ref. 32).
650    07
$a senioři $7 D000368 $2 czmesh
650    07
$a senioři nad 80 let $7 D000369 $2 czmesh
650    07
$a ženské pohlaví $7 D005260 $2 czmesh
650    07
$a lidé $7 D006801 $2 czmesh
650    07
$a mužské pohlaví $7 D008297 $2 czmesh
650    17
$a warfarin $x farmakologie $x terapeutické užití $7 D014859 $2 czmesh
650    17
$a agregace trombocytů $x účinky léků $7 D010974 $2 czmesh
650    07
$a vyšetření funkce trombocytů $x metody $x přístrojové vybavení $x statistika a číselné údaje $7 D010979 $2 czmesh
650    07
$a INR $7 D019934 $2 czmesh
650    07
$a regresní analýza $7 D012044 $2 czmesh
650    07
$a statistika jako téma $7 D013223 $2 czmesh
650    07
$a ischemická choroba srdeční $x farmakoterapie $7 D017202 $2 czmesh
655    _7
$a klinická studie $7 D000068397 $2 czmesh
655    _7
$a práce podpořená grantem $7 D013485 $2 czmesh
700    1_
$a Moťovská, Zuzana $7 xx0104795 $u Department of Cardiology, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Fialová, Alena $7 stk2008461869 $u Department of Biostatistics, National Institute of Public Health, Prague, Czech Republic and Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Štětkářová, Ivana, $d 1963- $7 xx0030376 $u Department of Neurology, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Peisker, Tomáš $7 xx0141660 $u Department of Neurology, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Kalvach, Pavel, $d 1944- $7 jn20000710141 $u Department of Neurology, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
773    0_
$t Bratislavské lekárske listy $x 0006-9248 $g Roč. 122, č. 5 (2021), s. 320-324 $w MED00000845
856    41
$u http://www.elis.sk/download_file.php?product_id=7198&session_id=vqcv5omiqd8n4relp2g02i6ia2 $y plný text volně přístupný
910    __
$a ABA008 $b online $c 1067 $y p $z 0
990    __
$a 20211012144111 $b ABA008
991    __
$a 20250218232652 $b ABA008
999    __
$a ok $b bmc $g 1715522 $s 1147873
BAS    __
$a 3 $a 4
BMC    __
$a 2021 $b 122 $c 5 $d 320-324 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845
LZP    __
$c NLK189 $d 20250218 $a NLK 2021-43/kv

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...